Rosoxacin
|
WikiDoc Resources for Rosoxacin |
|
Articles |
|---|
|
Most recent articles on Rosoxacin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Rosoxacin at Clinical Trials.gov Clinical Trials on Rosoxacin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Rosoxacin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Rosoxacin Discussion groups on Rosoxacin Directions to Hospitals Treating Rosoxacin Risk calculators and risk factors for Rosoxacin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Rosoxacin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Rosoxacin (tradename Eradacil®) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States.
It was developed by Sanofi-Synthelabo (now part of sanofi-aventis).